activity
20192022
most citedScalable Reinforcement-Learning-Based Neural Architecture Search for Cancer Deep Learning Research

35 citations · 101 across the 12 of their papers we have counts for

collaborators
Showing 2020Show all

5 papers · 1 filter

q-bio.QM2020

Learning Curves for Drug Response Prediction in Cancer Cell Lines

Alexander Partin, Thomas Brettin, Yvonne A. Evrard +9

Motivated by the size of cell line drug sensitivity data, researchers have been developing machine learning (ML) models for predicting drug response to advance cancer treatment. As…

cs.DC2020★ 3 cited

IMPECCABLE: Integrated Modeling PipelinE for COVID Cure by Assessing Better LEads

Aymen Al Saadi, Dario Alfe, Yadu Babuji +33

The drug discovery process currently employed in the pharmaceutical industry typically requires about 10 years and $2-3 billion to deliver one new drug. This is both too expensive…

q-bio.BM2020★ 20 cited

Targeting SARS-CoV-2 with AI- and HPC-enabled Lead Generation: A First Data Release

Yadu Babuji, Ben Blaiszik, Tom Brettin +15

Researchers across the globe are seeking to rapidly repurpose existing drugs or discover new drugs to counter the the novel coronavirus disease (COVID-19) caused by severe acute re…

q-bio.QM2020★ 8 cited

Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response

Yitan Zhu, Thomas Brettin, Yvonne A. Evrard +6

Transfer learning has been shown to be effective in many applications in which training data for the target problem are limited but data for a related (source) problem are abundant…

cs.LG2020★ 7 cited

A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning

Austin Clyde, Tom Brettin, Alexander Partin +6

By combining various cancer cell line (CCL) drug screening panels, the size of the data has grown significantly to begin understanding how advances in deep learning can advance dru…